Related Experiment Videos
New antifungals selected by molecular topology
L Pastor1, R García-Domenech, J Gálvez
1Unidad de Investigación de Diseño de Fármacos, Facultad de Farmacia, Universitat de Valencia, Spain.
Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
Summary
Molecular topology identified novel antimycotic compounds. Three compounds, including 3,3
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Mycology
Background:
- Antimycotic drug discovery is crucial for combating fungal infections.
- Existing treatments face challenges like resistance and side effects.
- Novel chemical scaffolds are needed to develop new antifungal agents.
Purpose of the Study:
- To explore the utility of molecular topology in identifying novel antimycotic compounds.
- To screen and evaluate potential lead compounds with antifungal activity.
Main Methods:
- Application of molecular topology principles for compound selection.
- Synthesis and purification of selected candidate molecules.
- Determination of minimum inhibitory concentrations (MICs) against target fungi.
Main Results:
- Identified three promising lead antimycotic compounds: 3,3'-(4,4'-Biphenylene)bis(2,5-diphenyl-2H-tetrazolium chloride), Benztropine mesylate, and Dicyclopentamethylenethiuram disulphide.
- These compounds exhibited potent antifungal activity with MICs ranging from 1.6 to 2 µg/mL.
- Demonstrated the effectiveness of molecular topology in guiding the discovery of new antimycotic agents.
Conclusions:
- Molecular topology is a valuable approach for discovering novel antimycotic drug candidates.
- The identified compounds represent promising leads for further development into effective antifungal therapies.
- Further research is warranted to optimize these compounds and assess their in vivo efficacy and safety profiles.